Pharmacokinetics and conjugation metabolism of naringin and naringenin in rats after single dose and multiple dose administrations

Journal of Food and Drug Analysis

Volumn 14, Issue 3, 2006, Pages 247-253

  Wang, Meng Ju ^a   Chao, Pei Dawn Lee ^a   Hou, Yu Chi ^a   Hsiu, Su Lan ^a   Wen, Kuo Ching ^a   Tsai, Shang Yuan ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Glucuronides; Naringenin; Naringin; Pharmacokinetics; Sulfates

Indexed keywords

AURANTIIN; BETA GLUCURONIDASE; DRUG METABOLITE; FLAVONOID; NARINGENIN; SULFATASE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; BOLUS INJECTION; CITRUS FRUIT; CONTROLLED STUDY; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG CONJUGATION; DRUG HALF LIFE; DRUG HYDROLYSIS; DRUG METABOLISM; DRUG STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MULTIPLE DRUG DOSE; NONHUMAN; RAT; SINGLE DRUG DOSE; STEADY STATE; TREATMENT DURATION;

CITRUS;

EID: 33751370317     PISSN: 10219498     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Hollman, P. C. H. and Katan, M. B. 1999. Dietary flavonoids: Intake, health effects and bioavailability. Food Chem Toxicol. 37: 937-942.
2. O'Reilly, J. D., Sanders, T. A. and Wiseman, H. 2000. Flavonoids protect against oxidative damage to LDL in vitro: use in selection of a flavonoid rich diet and relevance to LDL oxidation resistance ex vivo? Free Radic Res. 33: 419-26.
3. Scalbert, A. and Williamson, G. 2000. Dietary intake and bioavailability of polyphenols. J. Nutr. 130: 2073S-2085S.
4. Martin, M. J., Marhuenda, E., Perez, G. C. and France, J. M. 1994. Antiulcer effect of naringin on gastric lesions induced by ethanol in rats. Pharmacology. 49: 144-150.
5. Cushnie, T. P. and Lamb, A. J. 2005. Antimicrobial activity of flavonoids. Int J. Antimicrob Agents. 26: 343-56.
6. Chen, Y. T., Zheng, R. L., Jia, Z. J. and Ju, Y. 1990. Flavonoids as superoxide scavengers and antioxidants. Free Radic Biol Med. 9: 19-21.
7. Kim, H. J., Oh, G. T., Park, Y. B., Lee, M. K., Seo, H. J. and Choi, M. S. 2004. Naringin alters the cholesterol biosynthesis and antioxidant enzyme activities in LDL receptor- knockout mice under cholesterol fed condition. Life Sci. 74: 1621-34.
8. Harmon, A. W. and Patel, Y. M. 2004. Naringenin inhibits glucose uptake in MCF-7 breast cancer cells: a mechanism for impaired cellular proliferation. Breast Cancer Res Treat. 85: 103-10.
9. Frydoonfar, H. R., McGrath, D. R. and Spigelman, A. D. 2003. The variable effect on proliferation of a colon cancer cell line by the citrus fruit flavonoid naringenin. Colorectal Dis. 5: 149-52.
10. Hsiu, S. L., Huang, T. Y., Hou, Y. C., Chin, D. H. and Chao, P.D. 2002. Comparison of metabolic pharmacokinetics of naringin and naringenin in rabbits. Life Sci. 70: 1481-9.
11. Jin, D., Hakamata, H., Takahashi, K., Kotani, A. and Kusu, F. 2004. Determination of quercetin in human plasma after ingestion of commercial canned green tea by semi-micro HPLC with electrochemical detection. Biomed Chromatogr. 18: 662-6.
12. Higaki, K., Ishii, M., Esumi, H., Kanayama, M., Ogawara, K. I. and Kimura, T. 2003. Pharmacokinetic analysis of factors determining elimination pathways for sulfate and glucuronide metabolites of xenobiotics II: Studies with isolated perfused rat liver. Xenobiotica. 33: 1097-1108.
13. Takenaka, O., Horie, T., Suzuki, H. and Sugiyama, Y. 1997. Carrier-mediated active transport of the glucuronide and sulfate of 6-hydroxy-5,7-dimethyl-2- methyl-amino-4-(3-pyridylmethyl)benzothiazole (E3040) into rat liver: Quantitative comparison of permeability in isolated hepatocytes, perfused liver and liver in vivo. J Pharmacol Exp Ther. 280: 948-958.
14. Walle, T. 2004. Absorption and metabolism of flavonoids. Free Radic Biol Med. 36: 829-37.
15. Fang, S. H., Hou, Y. C., Chang, W. C., Hsiu, S. L. and Chao, P. D. L., Chiang, B.L. 2003. Morin sulfates/glucuronindes exert anti-inflammatory activity on activated macrophages and decreased the incidence of septic shock. Life Sci. 74: 743-56.
16. O'Leary, K. A., Day, A. J., Needs, P. W., Sly, W. S. and O'Brien, N. M., Williamson, G. 2001. Flavonoid glucuronides are substrates for human liver beta-glucuronidase. FEBS Lett. 503: 103-6.
17. Shimoi, K., Saka, N., Nozawa, R., Sato, M., Amano, I., Nakayama, T. and Kinae, N. 2001. Deglucuronidation of a flavonoid, luteolin monoglucuronide, during inflammation. Drug Metab Dispos. 29: 1521-4.